An AI model for prostate MRI offered an 89 percent AUC for prostate cancer detection in external validation testing, according to a newly published international multicenter study.
|Articles|May 8, 2012
FDA Clears Hitachi’s Widest Bore MR System
Author(s)Diagnostic Imaging Staff
The Echelon Oval has a patient-shaped design, resulting in a 74-cm oval bore - the widest in the industry, the company said.
Advertisement
Hitachi Medical Systems America Inc. has received FDA clearance for its 1.5T MRI with the widest bore in the industry.The Echelon Oval has a patient-shaped design, resulting in a 74-cm oval bore. The system’s increased space will particularly benefit patients who are claustrophobic or anxious, the company said.
Echelon Oval delivers high diagnostic confidence with the suite of advanced imaging techniques, including non-contrast MRA, isotropic image acquisition, and robust fat suppression, the company said. The system also includes patient-friendly features such as an integrated coil system and wide mobile table.
Advertisement
Related to this article
Catch up on the top radiology content of the past week.
The cloud-based NextMR platform reportedly provides automated 3D bone images of conventional spine MRI images in less than 60 seconds.
Incorporation of pseudocapsule presence into a modified Clear Cell Likelihood Score (m-ccLS) was associated with a greater than 11 percent higher AUC in differentiating benign and malignant renal masses on mpMRI, according to a new study.
The AI-powered SwiftSight Body Composition software reportedly provides automated quantification of muscle and adipose tissue after a brief MRI scan.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Breast Imaging in Focus: Can AI Models for Breast Cancer Detection and Risk Prediction Be Used Interchangeably?
2
Molecular Imaging in Focus: Comparative PSMA PET Study Offers Insights for Men with Recurrent PCa and Low PSA Values
3
What a Large Prostate MRI Study Reveals About AI and Unassisted Radiologist Assessment
4
Can CT Bone Reading Software Enhance Detection of Metastatic Rib Lesions in Women with Breast Cancer?
5